Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19

NCT05761652 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT05761652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05761652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2022
Completion date
June 1, 2024
Enrollment
378 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19